Ledger.Open graph →
SEC Form D · filed November 16, 2022

Jnana Therapeutics Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Matthew W. Hammond · Boston, MADirectorTerrance G. Mcguire · Boston, MADirectorDonald W. Nicholson · Boston, MADirectorJoanne D. Kotz · Boston, MAExec · DirectorCarlo W. Rizzuto · Boston, MADirectorBrian M. Cali · Boston, MADirectorJoel S. Barrish · Boston, MAExecCaroline S. Beer · Boston, MAExecAnnie C. Chen · Boston, MADirectorThomas Vetrano · NEW YORK, NYDirectorJohn C. Sykes · NEW YORK, NYExecGavin J. Kalin · New York, NYDirectorJohn A. Rogers · New York, NYDirectorMichael Burton · Orleans, INExec · DirectorMatt Echols · NEW YORK, NYDirectorRadha Swaminathan · NEW YORK, NYExecKevin Strott · Castle Rock, CODirectorBenjamin Lowy · New York, NYDirectorDouglas W. Pagan · Boston, MAExecRonald C. Renaud, Jr · Cambridge, MADirectorThomas A. Sargent · Boston, MAExecClark Yuan · Tacoma, WADirectorYaron Shemesh · Englewood Cliffs, NJExecLily Kao · Boston, MADirectorPaul Yoo · PLEASANT HILL, CADirectorReiner Laus · San Diego, CADirectorShivarupam Bhowmik · San Diego, CADirectorJeffrey Friedman · San Diego, CAExec · DirectorFred S. Dillard · Snyder, TXDirectorDouglas W. Pagan · Boston, MAExecRonald C. Renaud, Jr · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗